Alnylam/Regeneron Face Crowded IgA Nephropathy Field, But Combinations Likely

 
• By Alaric DeArment
  
Alnylam announced Phase II data for cemdisiran in IgA nephropathy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Genitourinary

More from Therapeutic Category